Advisor Resource Council Invests $2.23 Million in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Advisor Resource Council acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 27,337 shares of the company's stock, valued at approximately $2,232,000. Advisor Resource Council owned about 0.06% of Prestige Consumer Healthcare as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently bought and sold shares of PBH. Charles Schwab Investment Management Inc. boosted its position in shares of Prestige Consumer Healthcare by 5.6% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 636,020 shares of the company's stock worth $49,667,000 after purchasing an additional 33,844 shares during the last quarter. Norges Bank bought a new position in Prestige Consumer Healthcare during the fourth quarter worth about $40,009,000. BNP Paribas Financial Markets boosted its holdings in Prestige Consumer Healthcare by 1,073.3% during the fourth quarter. BNP Paribas Financial Markets now owns 203,903 shares of the company's stock worth $15,923,000 after buying an additional 186,524 shares during the last quarter. Wealth Enhancement Advisory Services LLC grew its position in shares of Prestige Consumer Healthcare by 14.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 8,315 shares of the company's stock worth $649,000 after buying an additional 1,030 shares during the period. Finally, Principal Financial Group Inc. increased its stake in shares of Prestige Consumer Healthcare by 3.2% in the 4th quarter. Principal Financial Group Inc. now owns 256,526 shares of the company's stock valued at $20,032,000 after acquiring an additional 7,890 shares during the last quarter. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Down 0.3%

PBH traded down $0.27 during trading on Friday, reaching $83.37. The company had a trading volume of 362,361 shares, compared to its average volume of 298,971. The company has a market cap of $4.12 billion, a P/E ratio of 19.43, a PEG ratio of 2.50 and a beta of 0.45. Prestige Consumer Healthcare Inc. has a 12 month low of $64.94 and a 12 month high of $90.04. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.20 and a quick ratio of 2.82. The business's fifty day moving average price is $83.93 and its 200 day moving average price is $82.51.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.30 by $0.02. The business had revenue of $296.52 million for the quarter, compared to analysts' expectations of $289.36 million. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The firm's revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.02 EPS. Equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

Several research firms recently weighed in on PBH. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a research note on Thursday, May 8th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, May 17th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat, Prestige Consumer Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.